Clinical Trials Logo

Depressive Disorder clinical trials

View clinical trials related to Depressive Disorder.

Filter by:
  • Completed  
  • Page 1 ·  Next »

NCT ID: NCT06464627 Completed - Depression Clinical Trials

Physical Activity Reduces Anxiety and Depression in Youth Affected by Displacement: a Randomized Controlled Trial of the Game Connect Program in Uganda

Game Connect
Start date: September 1, 2022
Phase: N/A
Study type: Interventional

This randomized controlled trial investigated 12 weeks of physical activity or to 12 weeks in a waiting control condition in youth aged 15 to 24 years old affected by displacement.

NCT ID: NCT06457061 Completed - Depression Clinical Trials

Evaluation of Caregiver Burden and Depression Severity in Patients With Hemiplegia

Start date: June 1, 2023
Phase:
Study type: Observational

This study aimed to evaluate the caregiving burden and severity of depression in patients with right hemiplegia and left hemiplegia.

NCT ID: NCT06456775 Completed - Depression Clinical Trials

Tele-SSM: A Telephone Technology Innovation in the Intervention on Supported Self-management for Depression in Vietnam

Start date: February 2, 2021
Phase: N/A
Study type: Interventional

Tele-SSM is a pre-post mixed-method study to investigate the feasibility, acceptability and the preliminary efficacy of the support self-management skills intervention for depression delivered from distance. The specific objectives of this research include: - Transform the SSM intervention for depression from face-to-face delivery to delivery from distance. - Develop an software for intervention management - Examine knowledge, attitudes and practices of people with depression toward depression - Examine the feasibility, acceptability and preliminary efficacy of the intervention - Investigate the cost analysis of Tele-SSM intervention

NCT ID: NCT06439797 Completed - Clinical trials for Major Depressive Disorder

Inflammatory Markers as Predictors of the Efficacy of Electroconvulsive Therapy (ECT) in Major Depression Patients

ECT MDD
Start date: November 29, 2018
Phase:
Study type: Observational

Background: ECT is an effective treatment indicated for patients with treatment resistant depression. Although most patients display some degree of recovery, 32-52% do not respond or remit at all. Considering the possible side effects and the considerably high cost of treatment, it is important to identify sub-populations that would benefit the most from ECT. In the current study we sought to identify predictive molecular markers in the blood of depressed patients who are responsive to ECT. Methods: Patients, ages 18-70, with the diagnosis of treatment-resistant depression will be recruited. Participants will undergo psychiatric and psychological assessments, before (baseline) and 12 weeks after ECT initiation. Assessments will include the Montgomery-Asberg Depression Rating Scale (MADRAS), Clinical Global Improvement and Severity Scales (CGI-S, CGI-I), Inventory of Depressive Symptomatology (IDS), and the State-Trait Anxiety Inventory (STAI). Blood samples for serum and isolation of peripheral blood mononuclear cells (PBMCs)will be collected at baseline and the 12-week end-of-treatment time points for molecular analysis.

NCT ID: NCT06429514 Completed - Depression Clinical Trials

Study on the Mechanism of Ganoderma Lucidum Spore Powder in the Treatment of Depression

Start date: March 28, 2023
Phase: N/A
Study type: Interventional

To clarify the clinical effect of Ganoderma lucidum spore powder intervention on postoperative depressive symptoms of papillary thyroid carcinoma ; to elucidate the antidepressant mechanism of Ganoderma lucidum spore powder.

NCT ID: NCT06427902 Completed - Depression Clinical Trials

Inflammatory Biomarkers in Saliva at Depression

Start date: December 10, 2018
Phase:
Study type: Observational

The goal of this observational study is to evaluate the inflammatory saliva biomarkers in depression and gingivitis. The main question will be ; Will there be an increase at salivary biomarkers with depression patients and is it associated with gingivitis?

NCT ID: NCT06424496 Completed - Clinical trials for Postpartum Depression

Effect of Targeted Health Education Program on Nurses' Awareness About Postpartum Depression

PPD
Start date: February 28, 2024
Phase: N/A
Study type: Interventional

To assess nurses' knowledge of PPD at Ain Shams University Maternity Hospital and measure their knowledge level after an educational program on postpartum depression.

NCT ID: NCT06414226 Completed - Depression Clinical Trials

Comparison of Krill and Fish Oil on Clinical and Biochemical Outcomes in Depression

Start date: March 21, 2022
Phase: N/A
Study type: Interventional

The Omega-3 polyunsaturated fatty acids (n-3 PUFA), associated with fish oil, has been one of the most studied non-pharmacological subjects for its effect on Major Depression Disorder (MDD). However, studies comparing the effect of krill oil, on depression are limited, that has similar content and different structural forms with fish oil. This study was conducted to evaluate the effectiveness of the use of krill and fish oil on clinical effects, biochemical outcomes and eating behavior in individuals diagnosed with MDD. It was included 57 adult individuals diagnosed with MDD in the psychiatry clinic in this study. Randomization was performed after inclusion and exclusion criteria were applied in the study, and participants were included in one of three groups. These groups are; 1) krill oil ((n=17), (Eicosapentaenoic acid (EPA)=340 mg, Docosahexaenoic acid (DHA)=180 mg)), 2) fish oil ((n=17)), (EPA=360 mg, DHA=240 mg), 3) placebo ( (n=16), (EPA=0 mg, DHA=0 mg)). The duration of the intervention was 8 weeks. Anthropometric measurements, biochemical outcomes and food consumption records of the participants were taken at the beginning and end of the intervention, and Hamilton depression rating scale (HDRS), depression anxiety stress-21 (DASS-21) and food craving questionnaire (FCQ) was applied to the participants. Statistical Package for Social Sciences (SPSS) and R studio software were used for statistical analysis of the data.

NCT ID: NCT06377176 Completed - Clinical trials for Postpartum Depression

Postpartum Massage Therapy for Women and Infants: The Effect on Maternal Depression, Stress, Fatigue and Infant Temperament

Start date: June 16, 2021
Phase: N/A
Study type: Interventional

Mother and infant massage, a type of complementary therapy, possesses the capacity to ameliorate maternal depression, stress, fatigue, and also infant temperaments and convert them into more manageable ones. The objective of this study was to determine the effect of mother and infant massage therapy on maternal depression, stress, fatigue, and infant temperament. In this quasi-experimental study, a total of 102 participants were allocated into two groups based on a pretest and posttest. During a period of five weeks, the experimental groups were subjected to ten massages per week, twice every week. On the data, a generalized estimating equation (GEE) was implemented. This study's hypothesis was an improvement in maternal depression, stress, fatigue, and infant temperament.

NCT ID: NCT06372210 Completed - Schizophrenia Clinical Trials

A Trial to Assess a Wearable Patch's Functioning to Detect Medication Ingestion

Start date: June 26, 2023
Phase: N/A
Study type: Interventional

The primary purpose of the study is to evaluate the positive detection accuracy (PDA) and detection latency measures of the D-Tect patch.